awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48107095-C37E01E8-F980-43BA-A7CC-54ADA9CDE659
Q48107095-C37E01E8-F980-43BA-A7CC-54ADA9CDE659
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48107095-C37E01E8-F980-43BA-A7CC-54ADA9CDE659
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.
P2860
Q48107095-C37E01E8-F980-43BA-A7CC-54ADA9CDE659
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48107095-C37E01E8-F980-43BA-A7CC-54ADA9CDE659
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2489412b36986f026c917b4ba1d1739fbef949c
P2860
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.